Androgen Receptor-Induced Integrin α6β1 and Bnip3 Promotes Survival and Resistance to PI3K Inhibitors in Castration-Resistant Prostate Cancer

The androgen receptor (AR) is the major driver of prostate cancer growth and survival. However, almost all patients relapse with castration resistant disease (CRPC) when treated with anti-androgen therapy. In CRPC, AR is often aberrantly activated independent of androgen. Targeting survival pathways...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncogene
Huvudupphovsmän: Nollet, Eric A., Cardo-Vila, Marina, Ganguly, Sourik S., Tran, Jack D., Schulz, Veronique V., Cress, Anne, Corey, Eva, Miranti, Cindy K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7395876/
https://ncbi.nlm.nih.gov/pubmed/32565538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1370-9
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk